Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Retatrutide is a synthetic triple-receptor agonist peptide targeting the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) simultaneously, studied extensively across metabolic biology, obesity research, energy expenditure, and cardiovascular science for its unmatched tri-agonist incretin action and superior metabolic influence compared to single and dual-receptor compounds making it the most advanced and broadly acting incretin research peptide currently available in modern metabolic science
Improved metabolic health and cardiovascular risk reduction: Semaglutide suits those with a history of heart disease
program availability varies by state
In a cursory Google search, Futurism also found that search engine provides sponsored results for even more unregulated semaglutide and tirzepatide, even though the companys own guidelines forbid running ads for pharmacies selling prescription drugs without a prescription
US$ 29.32
US$ 24.96
US$ 22.49
US$ 28.61
